IMVT
Immunovant Inc
37.00$
-1.9%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|
| – | +257.9% | +26,909.1% | +277.1% | +25.0% | -21.3% | +64.3% | +16.4% | +23.4% | |
| – | +187.2% | +33,461.8% | +275.0% | +25.4% | -21.2% | +64.7% | +15.3% | +23.6% | |
| – | – | +30,844.9% | +297.9% | +23.4% | -23.8% | +68.7% | +12.4% | +26.4% | |
| – | – | +30,844.9% | +297.9% | +23.4% | -23.8% | +68.7% | +12.4% | +26.4% | |
| – | – | +2.8% | -62.4% | +1,024.2% | -93.1% | +521.8% | -54.4% | +57.1% | |
| – | – | – | – | – | – | – | – | – | |
| – | – | +20.4% | +209.2% | +64.2% | +0.9% | – | – | – | |
| – | -76.4% | +3,926.3% | +37.2% | +117.7% | -5.2% | +12.9% | +40.5% | +52.6% | |
| – | -76.4% | +3,926.3% | +22.5% | +137.2% | -2.7% | +12.3% | +41.5% | +51.8% | |
| – | – | +963.3% | -63.0% | -2.9% | +2.4% | -88.2% | -29.0% | -26.5% | |
| – | -100.0% | +577,569.9% | +104.4% | +666.0% | -92.7% | +428.8% | +146.8% | -57.3% | |
| – | – | +383,041.9% | +316.2% | +20.0% | -22.8% | +70.4% | +14.5% | +20.5% | |
| – | – | – | – | – | – | – | – | – | |
| – | +43.8% | +200.5% | +103.1% | +25.0% | +12.2% | +12.2% | +9.8% | +20.4% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.